Regional Reports

SOUTH BAY

ROSEWOOD

Digital Facelift: Thrive Furniture, a Rosewood maker and retailer of midcentury-inspired furnishings, has redesigned its website. The relaunched site now includes 70 more products. Thrive is owned by furniture company Versa Products Inc., also based in Rosewood.

NORTH COUNTY

VALENCIA

Outpatient Outpost: Children’s Hospital Los Angeles, a Los Feliz pediatrics hospital, has opened a 4,000-square-foot outpatient center in Valencia. The new location, at 23838 Valencia Blvd., will be serviced by nine Children’s Hospital physicians. The new center is the second Children’s Hospital outpatient center; the other one is in Arcadia.

SAN FERNANDO VALLEY

WOODLAND HILLS

Public Listing: The common stock of ImmunoCellular Therapeutics Ltd., a Woodland Hills biotech focused on cancer treatments, has been approved for listing on the New York Stock Exchange. The company’s stock will trade under ticker symbol IMUC.

WESTSIDE

WESTWOOD

Flexible Schedule: UCLA Anderson School of Management has added a scheduling option for its Fully Employed M.B.A. program, which allows students to work part time toward a degree. Through the Flex Femba program, a portion of course work will be conducted online and through collaborative group work. The new program is designed to keep students’ visit campus to a minimum, with classes scheduled on the weekends. Flex Femba will be available for the first time this fall.

WEST LOS ANGELES

Building Acquired: Maui Brian Properties LLC has purchased a West L.A. office building for $3.3 million from 2040 Stoner Properties LLC. The 10,000-square-foot property, at 2040 Stoner Ave., sits on an almost half-acre and was built in 1950. The new owner will utilize the office building for his toy company. 

SAN GABRIEL VALLEY

MONROVIA

Name Change: Ewing & Beland Inc., a Monrovia strategic design and media company founded in 1983, will change its name to Mad Haus Creative Inc. this month. The company will remain at 517 S. Ivey Ave.

DUARTE

Research Funding: City of Hope, a Duarte disease research and treatment institution, has been granted a $5.2 million early translational research award by the California Institute for Regenerative Medicine, which was established in 2004 with the passage of Proposition 71, the California Stem Cell Research and Cures Act. The money will support the development of a T cell-based immunotherapy that redirects a patient’s immune response. City of Hope has been awarded more than $49.7 million in grant support from Cirm since awards were first announced in 2006.